Parkinson's Disease Trial, Recruiting NCT06663826 Sponsor: machineMD AG Condition: Parkinson's Disease
Back to Parkinsons Disease

Parkinson's Disease Trial, Recruiting

NCT06663826
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You have been diagnosed with Parkinson's disease or a related condition sometimes called "atypical Parkinson's"
  • Your eyesight prescription (glasses or contacts) falls within a moderate range — between -6 and +4 diopters in both eyes
  • You are willing and able to sign a consent form agreeing to take part
  • You are able to describe from your own experience that you have daily episodes of "freezing" while walking (where your feet feel stuck) and/or shuffling/speeding up uncontrollably
  • You are able to walk for at least 5 minutes, with or without a walking aid, and if you are aged 70 or older, this level of activity is something you are already used to doing

Who may not be able to join:

  • You have another known neurological condition (other than Parkinson's or a related condition)
  • You are currently taking certain medications or substances — such as sedatives (e.g. benzodiazepines), alcohol, stimulants, or recreational drugs — that the trial team believe could affect your eye movements or your ability to take part (Parkinson's medications are not included in this restriction)
  • You are unable to understand or follow the study instructions, for example due to significant memory or thinking difficulties
  • You have an injury or health condition (unrelated to Parkinson's) that affects your eye movements or your balance
  • You have any skin problems, wounds, or broken skin on your calf or behind your knee
  • You do not have access to WiFi at home, or your home WiFi connection is unreliable

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 8 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Konrad Weber, Prof. Dr. med., University of Zurich

Phone: +41 (0)31 589 67 92

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
machineMD AG
Registry
ClinicalTrials.gov
Start date
1 October 2024
Est. completion
30 June 2026

Where this trial is recruiting

🇨🇭 Switzerland

Primary endpoints

Development of machine learning models for diagnosing and monitoring of PD

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 8 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov